login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NOVO-NORDISK A/S-SPONS ADR (NVO) Stock News
USA
- NYSE:NVO -
US6701002056
-
ADR
48.26
USD
-0.9 (-1.83%)
Last: 11/14/2025, 8:10:41 PM
48.2293
USD
-0.03 (-0.06%)
After Hours:
11/14/2025, 8:10:41 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NVO Latest News, Press Relases and Analysis
All
Press Releases
10 days ago - By: Chartmill
Novo Nordisk A/S-Spons ADR (NYSE:NVO) Embodies Affordable Growth Strategy
13 days ago - By: Chartmill
Novo Nordisk A/S (NYSE:NVO): A Top Dividend Stock with Strong Profitability and Financial Health
a day ago - By: Benzinga
- Mentions:
RAY
DAY
MTSR
PSKY
...
Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market
a day ago - By: Stocktwits
- Mentions:
DFAX
NDVG
LLY
Novo Nordisk Brings Back Former CEO To Lead Board
2 days ago - By: Stocktwits
- Mentions:
SRRK
VFMO
IWMW
Why Did Scholar Rock Soar 26% Today?
2 days ago - By: Benzinga
- Mentions:
LLY
PFE
MGRX
MTSR
Ozempic Maker Novo Nordisk Faces Board Shakeup
2 days ago - By: Zacks Investment Research
- Mentions:
LLY
AMGN
VKTX
Can Lilly's Next-Gen Obesity Drugs Help Sustain Its Market Dominance?
2 days ago - By: The Motley Fool
Is It Too Late to Buy Novo Nordisk After the Drop?
2 days ago - By: Stocktwits
- Mentions:
MTSR
PFE
LLY
Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO
2 days ago - By: Stocktwits
- Mentions:
CDTX
MRK
VRNA
PFE
...
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium
2 days ago - By: Zacks Investment Research
- Mentions:
NVDA
INTC
AI Frenzy: Everybody Wants NVIDIA's Magical GPUs
2 days ago - By: Stocktwits
- Mentions:
PFE
MTSR
VZ
TSLA
Pfizer CEO Sees Metsera’s Drugs Hit Market As Early As 2028 After Completing Acquisition: Report
3 days ago - By: Stocktwits
- Mentions:
MGRX
LLY
Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs
3 days ago - By: The Motley Fool
- Mentions:
LLY
1 Incredible Reason to Buy LLY's Stock in November
4 days ago - By: Zacks Investment Research
- Mentions:
LLY
VKTX
Can NVO's Ozempic, Wegovy Sales Improve in 2026 After a Subdued Q3?
4 days ago - By: Stocktwits
- Mentions:
VKTX
MTSR
PFE
LLY
...
‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios
5 days ago - By: Zacks Investment Research
- Mentions:
LLY
VKTX
ADVM
Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock?
6 days ago - By: Zacks Investment Research
- Mentions:
LLY
VKTX
Will Lower GLP-1 Prices Undermine Novo Nordisk's Near-Term Outlook?
6 days ago - By: Investor's Business Daily
- Mentions:
PFE
MTSR
Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion
6 days ago - By: Zacks Investment Research
- Mentions:
PFE
MTSR
Pfizer Wins Obesity War Against NVO, to Buy Metsera for Around $10B
6 days ago - By: Zacks Investment Research
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
6 days ago - By: Zacks Investment Research
- Mentions:
LLY
PFE
ABBV
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs?
6 days ago - By: Stocktwits
- Mentions:
PFE
MTSR
AKRO
VKTX
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith
Please enable JavaScript to continue using this application.